SE417603B - Forfarande for framstellning av derivat av 8-aza-11-deoxiprostaglandin e?711 med terapeutiska egenskaper - Google Patents

Forfarande for framstellning av derivat av 8-aza-11-deoxiprostaglandin e?711 med terapeutiska egenskaper

Info

Publication number
SE417603B
SE417603B SE7703698A SE7703698A SE417603B SE 417603 B SE417603 B SE 417603B SE 7703698 A SE7703698 A SE 7703698A SE 7703698 A SE7703698 A SE 7703698A SE 417603 B SE417603 B SE 417603B
Authority
SE
Sweden
Prior art keywords
deoxiprostaglandin
aza
procedure
preparing derivatives
therapeutical properties
Prior art date
Application number
SE7703698A
Other languages
English (en)
Swedish (sv)
Other versions
SE7703698L (sv
Inventor
S Nanthavong
C Pigerol
P Eymard
J Simiand
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of SE7703698L publication Critical patent/SE7703698L/xx
Publication of SE417603B publication Critical patent/SE417603B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/126—Acids containing more than four carbon atoms
    • C07C53/128—Acids containing more than four carbon atoms the carboxylic group being bound to a carbon atom bound to at least two other carbon atoms, e.g. neo-acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
SE7703698A 1976-03-31 1977-03-30 Forfarande for framstellning av derivat av 8-aza-11-deoxiprostaglandin e?711 med terapeutiska egenskaper SE417603B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL49325A IL49325A (en) 1976-03-31 1976-03-31 8-aza-11-deoxy-pge1 derivatives,their preparation and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
SE7703698L SE7703698L (sv) 1977-10-01
SE417603B true SE417603B (sv) 1981-03-30

Family

ID=11048789

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7703698A SE417603B (sv) 1976-03-31 1977-03-30 Forfarande for framstellning av derivat av 8-aza-11-deoxiprostaglandin e?711 med terapeutiska egenskaper

Country Status (18)

Country Link
US (1) US4115401A (en, 2012)
JP (1) JPS52142060A (en, 2012)
BE (1) BE852941A (en, 2012)
CA (1) CA1074804A (en, 2012)
CH (2) CH624101A5 (en, 2012)
DD (1) DD130352A5 (en, 2012)
DE (1) DE2714129A1 (en, 2012)
ES (1) ES457385A1 (en, 2012)
FR (1) FR2346332A1 (en, 2012)
GB (1) GB1574246A (en, 2012)
HU (1) HU178040B (en, 2012)
IL (1) IL49325A (en, 2012)
IT (1) IT1075373B (en, 2012)
NL (1) NL7703503A (en, 2012)
NO (1) NO149428C (en, 2012)
PL (3) PL108289B1 (en, 2012)
SE (1) SE417603B (en, 2012)
SU (3) SU676162A3 (en, 2012)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA793452B (en) * 1978-07-11 1980-06-25 Glaxo Group Ltd Prostanoid compounds
US4320136A (en) * 1980-08-11 1982-03-16 E. I. Du Pont De Nemours And Company 8-Aza-16,16-difluoroprostanoids
US4456613A (en) * 1982-12-27 1984-06-26 E. I. Du Pont De Nemours And Company 6-Keto- and 6-hydroxy-8-azaprostanoids and anti-ulcer use thereof
US4530933A (en) * 1982-12-27 1985-07-23 E. I. Du Pont De Nemours And Company 8-Aza-13-thiaprostanoids and a method of use thereof as anti-ulcer agents
AU1293101A (en) 1999-12-22 2001-07-03 Pfizer Products Inc. Ep4 receptor selective agonists in the treatment of osteoporosis
ES2291361T3 (es) * 2000-11-27 2008-03-01 Pfizer Products Inc. Agonistas selectivos del receptor ep4 en el tratamiento de la osteoporosis.
CN100371322C (zh) * 2001-07-16 2008-02-27 霍夫曼-拉罗奇有限公司 作为前列腺素类化合物激动剂的2-吡咯烷酮衍生物
AU2002328855B2 (en) 2001-07-16 2005-11-24 F. Hoffmann-La Roche Ag Prostaglandin Analogues As EP4 Receptor Agonists
RU2303451C2 (ru) * 2001-07-23 2007-07-27 Оно Фармасьютикал Ко., Лтд. Фармацевтические композиции для лечения заболеваний, связанных с уменьшением костной массы, включающие агонист ер4 в качестве активного ингредиента
NZ535024A (en) 2002-03-05 2006-10-27 Ono Pharmaceutical Co 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
MXPA04009036A (es) * 2002-03-18 2005-01-25 Pfizer Prod Inc Uso de agonistas del receptor ep4 selectivos para el tratamiento de la insuficiencia hepatica, perdida de permeabilidad del ductus arterioso, glaucoma o hipertension ocular.
AU2004203905A1 (en) * 2003-01-10 2004-07-29 F. Hoffmann-La Roche Ag 2-piperidone derivatives as prostaglandin agonists
US7179820B2 (en) 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
US20080058375A1 (en) * 2004-01-08 2008-03-06 Elworthy Todd R 2-Piperidone derivatives as prostaglandin antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones

Also Published As

Publication number Publication date
ES457385A1 (es) 1978-02-01
PL108289B1 (pl) 1980-03-31
JPS52142060A (en) 1977-11-26
IL49325A (en) 1979-11-30
DE2714129A1 (de) 1977-10-13
US4115401A (en) 1978-09-19
SE7703698L (sv) 1977-10-01
HU178040B (en) 1982-02-28
PL107643B1 (pl) 1980-02-29
FR2346332B1 (en, 2012) 1980-05-09
DD130352A5 (de) 1978-03-22
IL49325A0 (en) 1976-05-31
BE852941A (fr) 1977-09-28
SU715019A3 (ru) 1980-02-05
PL197005A1 (pl) 1978-10-09
NO771134L (no) 1977-10-03
CA1074804A (en) 1980-04-01
NO149428C (no) 1984-04-18
SU837321A3 (ru) 1981-06-07
FR2346332A1 (fr) 1977-10-28
CH624101A5 (en, 2012) 1981-07-15
PL107544B1 (pl) 1980-02-29
NO149428B (no) 1984-01-09
NL7703503A (nl) 1977-10-04
IT1075373B (it) 1985-04-22
CH628032A5 (fr) 1982-02-15
SU676162A3 (ru) 1979-07-25
GB1574246A (en) 1980-09-03

Similar Documents

Publication Publication Date Title
SE423994B (sv) Forfarande for framstellning av terapentiskt verksamma derivat av prolin och pipekolinsyra
SE7700051L (sv) Forfarande for framstellning av l-(substituerd amino) alkanoyl-2-(dibesoxazepin-10-karbonyl)hydraziner och derivat derav
SE436741B (sv) Forfarande for framstellning av 15-deoxi-16-substituerade prostansyror och derivat derav
SE417603B (sv) Forfarande for framstellning av derivat av 8-aza-11-deoxiprostaglandin e?711 med terapeutiska egenskaper
NO794317L (no) Fremgangsmaate for fremstilling av pyrido-indolderivater
SE7606224L (sv) Forfarande for framstellning av heterocykliska acylaminoderivat
NO821847L (no) Fremgangsmaate for fremstilling av gamma-pyron-derivater
SE7803035L (sv) Forfarande for framstellning av tienopyridinderivat
NO784382L (no) Fremgangsmaate for fremstilling av tiazoldin-derivater
SE421528B (sv) Forfarande for framstellning av 8,8-disubstituerade 6-metylergoliner och derivat derav
SE7707407L (sv) Forfarande for framstellning av cefamderivat
SE423813B (sv) Forfarande for framstellning av 1,5-disubstituerade pyrrolidoner med terapeutiska egenskaper
SE434263B (sv) Forfarande for framstellning av kloretylnitrosokarbamider med antitumorverkan
NO771263L (no) Fremgangsm}te for fremstilling av indol-naftyridin-derivater
RO77308A (ro) Procedeu pentru prepararea derivatiilor aminochinazolinei substituite
SE7709402L (sv) Forfarande for framstellning av tetrahydropyridinderivat
NO780389L (no) Fremgangsmaate for fremstilling av erytromycin-derivater
NO792659L (no) Fremgangsmaate for fremstilling av karbostyrilderivater
NO801236L (no) Fremgangsmaate for fremstilling av halogenderivater av isopropylaminopyrimidin
SE7700572L (sv) Forfarande for framstellning av tienopyridinderivat
SE436496B (sv) Forfarande for framstellning av dibensotiofenderivat
NO801724L (no) Fremgangsmaate for fremstilling av ergopeptin-derivater
SE7702166L (sv) Forfarande for framstellning av derivat av cyklopenta (b) tiofen
SE406586B (sv) Nytt forfarande for framstellning av 3-fenyl-indol-2-sarbonitril och derivat derav
SE7706725L (sv) Forfarande for framstellning av cefemderivat